{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:03:53Z","timestamp":1792731833392,"version":"4.5.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2006,12,1]]},"DOI":"10.1038\/ncponc0666","type":"journal-article","created":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T05:37:51Z","timestamp":1164951471000},"page":"668-681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":315,"title":["Increased intensity lymphodepletion and adoptive immunotherapy\u2014how far can we go?"],"prefix":"10.1038","volume":"3","author":[{"given":"Pawel","family":"Muranski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Boni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Wrzesinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah E","family":"Citrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P","family":"Restifo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncponc0666_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","volume":"313","author":"SA Rosenberg","year":"1985","unstructured":"Rosenberg SA  et al. (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313: 1485\u20131492","journal-title":"N Engl J Med"},{"key":"BFncponc0666_CR2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1001\/jama.1994.03510360033032","volume":"271","author":"SA Rosenberg","year":"1994","unstructured":"Rosenberg SA  et al. (1994) Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 271: 907\u2013913","journal-title":"JAMA"},{"key":"BFncponc0666_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1200\/JCO.1989.7.4.477","volume":"7","author":"JP Dutcher","year":"1989","unstructured":"Dutcher JP  et al. (1989) A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma. J Clin Oncol 7: 477\u2013485","journal-title":"J Clin Oncol"},{"key":"BFncponc0666_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<89::AID-CNCR15>3.0.CO;2-4","volume":"77","author":"SS Legha","year":"1996","unstructured":"Legha SS  et al. (1996) Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma. Cancer 77: 89\u201396","journal-title":"Cancer"},{"key":"BFncponc0666_CR5","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nm1100","volume":"10","author":"SA Rosenberg","year":"2004","unstructured":"Rosenberg SA  et al. (2004) Cancer immunotherapy: moving beyond current vaccines. Nat Med 10: 909\u2013915","journal-title":"Nat Med"},{"key":"BFncponc0666_CR6","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/ni723","volume":"2","author":"J Derbinski","year":"2001","unstructured":"Derbinski J  et al. (2001) Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2: 1032\u20131039","journal-title":"Nat Immunol"},{"key":"BFncponc0666_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1084\/jem.20011658","volume":"195","author":"A Zippelius","year":"2002","unstructured":"Zippelius A  et al. (2002) Thymic selection generates a large T cell pool recognizing a self-peptide in humans. J Exp Med 195: 485\u2013494","journal-title":"J Exp Med"},{"key":"BFncponc0666_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1471-4906(03)00116-9","volume":"24","author":"FM Marincola","year":"2003","unstructured":"Marincola FM  et al. (2003) Tumors as elusive targets of T-cell-based active immunotherapy. Trends Immunol 24: 335\u2013342","journal-title":"Trends Immunol"},{"key":"BFncponc0666_CR9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/ni1102-999","volume":"3","author":"HT Khong","year":"2002","unstructured":"Khong HT and Restifo NP (2002) Natural selection of tumor variants in the generation of \u201ctumor escape\u201d phenotypes. Nat Immunol 3: 999\u20131005","journal-title":"Nat Immunol"},{"key":"BFncponc0666_CR10","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1002\/1521-4141(200109)31:9<2642::AID-IMMU2642>3.0.CO;2-6","volume":"31","author":"M Ayyoub","year":"2001","unstructured":"Ayyoub M  et al. (2001) Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing. Eur J Immunol 31: 2642\u20132651","journal-title":"Eur J Immunol"},{"key":"BFncponc0666_CR11","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.4049\/jimmunol.175.9.6169","volume":"175","author":"SA Rosenberg","year":"2005","unstructured":"Rosenberg SA  et al. (2005) Tumor progression can occur despite the induction of very high levels of self\/tumor antigen-specific CD8+ T cells in patients with melanoma. J Immunol 175: 6169\u20136176","journal-title":"J Immunol"},{"key":"BFncponc0666_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/ncponc0101","volume":"2","author":"SA Rosenberg","year":"2005","unstructured":"Rosenberg SA (2005) Cancer immunotherapy comes of age. Nat Clin Pract Oncol 2: 115","journal-title":"Nat Clin Pract Oncol"},{"key":"BFncponc0666_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nri1842","volume":"6","author":"L Gattinoni","year":"2006","unstructured":"Gattinoni L  et al. (2006) Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 6: 383\u2013393","journal-title":"Nat Rev Immunol"},{"key":"BFncponc0666_CR14","first-page":"197","volume":"4","author":"S Ross","year":"1993","unstructured":"Ross S  et al. (1993) Adoptive immunotherapy of hormone-refractory, stage D2 prostate cancer using ex vivo activated autologous T cells (autolymphocyte therapy): results from a pilot study. Biotechnol Ther 4: 197\u2013211","journal-title":"Biotechnol Ther"},{"key":"BFncponc0666_CR15","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1084\/jem.192.11.1637","volume":"192","author":"C Yee","year":"2000","unstructured":"Yee C  et al. (2000) Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med 192: 1637\u20131644","journal-title":"J Exp Med"},{"key":"BFncponc0666_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00002371-200107000-00012","volume":"24","author":"ME Dudley","year":"2001","unstructured":"Dudley ME  et al. (2001) Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother 24: 363\u2013373","journal-title":"J Immunother"},{"key":"BFncponc0666_CR17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1076514","volume":"298","author":"ME Dudley","year":"2002","unstructured":"Dudley ME  et al. (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298: 850\u2013854","journal-title":"Science"},{"key":"BFncponc0666_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1089\/hum.2005.16.457","volume":"16","author":"MS Hughes","year":"2005","unstructured":"Hughes MS  et al. (2005) Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions. Hum Gene Ther 16: 457\u2013472","journal-title":"Hum Gene Ther"},{"key":"BFncponc0666_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.it.2004.12.003","volume":"26","author":"CA Klebanoff","year":"2005","unstructured":"Klebanoff CA  et al. (2005) Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy. Trends Immunol 26: 111\u2013117","journal-title":"Trends Immunol"},{"key":"BFncponc0666_CR20","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1182\/blood-2003-01-0095","volume":"102","author":"GG Laport","year":"2003","unstructured":"Laport GG  et al. (2003) Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed\/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation. Blood 102: 2004\u20132013","journal-title":"Blood"},{"key":"BFncponc0666_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/00002371-200307000-00005","volume":"26","author":"ME Dudley","year":"2003","unstructured":"Dudley ME  et al. (2003) Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother 26: 332\u2013342","journal-title":"J Immunother"},{"key":"BFncponc0666_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1084\/jem.20050732","volume":"202","author":"L Gattinoni","year":"2005","unstructured":"Gattinoni L  et al. (2005) Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med 202: 907\u2013912","journal-title":"J Exp Med"},{"key":"BFncponc0666_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P  et al. (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"BFncponc0666_CR24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1056\/NEJM199008303230904","volume":"323","author":"SA Rosenberg","year":"1990","unstructured":"Rosenberg SA  et al. (1990) Gene transfer into humans\u2014immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 323: 570\u2013578","journal-title":"N Engl J Med"},{"key":"BFncponc0666_CR25","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","volume":"23","author":"ME Dudley","year":"2005","unstructured":"Dudley ME  et al. (2005) Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23: 2346\u20132357","journal-title":"J Clin Oncol"},{"key":"BFncponc0666_CR26","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1084\/jem.157.5.1448","volume":"157","author":"CD Mills","year":"1983","unstructured":"Mills CD and North RJ (1983) Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient: inhibition by suppressor T cells. J Exp Med 157: 1448\u20131460","journal-title":"J Exp Med"},{"key":"BFncponc0666_CR27","doi-asserted-by":"publisher","first-page":"9547","DOI":"10.1158\/0008-5472.CAN-05-1175","volume":"65","author":"LX Wang","year":"2005","unstructured":"Wang LX  et al. (2005) Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells. Cancer Res 65: 9547\u20139554","journal-title":"Cancer Res"},{"key":"BFncponc0666_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1084\/jem.20030590","volume":"198","author":"WW Overwijk","year":"2003","unstructured":"Overwijk WW  et al. (2003) Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med 198: 569\u2013580","journal-title":"J Exp Med"},{"key":"BFncponc0666_CR29","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.4049\/jimmunol.164.6.3087","volume":"164","author":"P Muranski","year":"2000","unstructured":"Muranski P  et al. (2000) Mature CD4+ T cells perceive a positively selecting class II MHC\/peptide complex in the periphery. J Immunol 164: 3087\u20133094","journal-title":"J Immunol"},{"key":"BFncponc0666_CR30","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1084\/jem.186.8.1269","volume":"186","author":"J Kirberg","year":"1997","unstructured":"Kirberg J  et al. (1997) Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 186: 1269\u20131275","journal-title":"J Exp Med"},{"key":"BFncponc0666_CR31","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.20030735","volume":"198","author":"RM Kondrack","year":"2003","unstructured":"Kondrack RM  et al. (2003) Interleukin 7 regulates the survival and generation of memory CD4 cells. J Exp Med 198: 1797\u20131806","journal-title":"J Exp Med"},{"key":"BFncponc0666_CR32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.288.5466.675","volume":"288","author":"CC Ku","year":"2000","unstructured":"Ku CC  et al. (2000) Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288: 675\u2013678","journal-title":"Science"},{"key":"BFncponc0666_CR33","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/80868","volume":"1","author":"KS Schluns","year":"2000","unstructured":"Schluns KS  et al. (2000) Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 1: 426\u2013432","journal-title":"Nat Immunol"},{"key":"BFncponc0666_CR34","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1084\/jem.20020033","volume":"195","author":"AW Goldrath","year":"2002","unstructured":"Goldrath AW  et al. (2002) Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med 195: 1515\u20131522","journal-title":"J Exp Med"},{"key":"BFncponc0666_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1084\/jem.20041057","volume":"201","author":"R Zeng","year":"2005","unstructured":"Zeng R  et al. (2005) Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med 201: 139\u2013148","journal-title":"J Exp Med"},{"key":"BFncponc0666_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1084\/jem.161.1.72","volume":"161","author":"S Sakaguchi","year":"1985","unstructured":"Sakaguchi S  et al. (1985) Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I: evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med 161: 72\u201387","journal-title":"J Exp Med"},{"key":"BFncponc0666_CR37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1084\/jem.192.4.557","volume":"192","author":"AW Goldrath","year":"2000","unstructured":"Goldrath AW  et al. (2000) Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 192: 557\u2013564","journal-title":"J Exp Med"},{"key":"BFncponc0666_CR38","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.4049\/jimmunol.167.10.5664","volume":"167","author":"M Prlic","year":"2001","unstructured":"Prlic M  et al. (2001) Homeostatic expansion occurs independently of costimulatory signals. J Immunol 167: 5664\u20135668","journal-title":"J Immunol"},{"key":"BFncponc0666_CR39","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.0105-2896.2006.00391.x","volume":"211","author":"CA Klebanoff","year":"2006","unstructured":"Klebanoff CA  et al. (2006) CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev 211: 214\u2013224","journal-title":"Immunol Rev"},{"key":"BFncponc0666_CR40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.coi.2006.03.009","volume":"18","author":"CS Hinrichs","year":"2006","unstructured":"Hinrichs CS  et al. (2006) Programming CD8+ T cells for effective immunotherapy. Curr Opin Immunol 18: 363\u2013370","journal-title":"Curr Opin Immunol"},{"key":"BFncponc0666_CR41","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/intimm\/5.11.1461","volume":"5","author":"F Powrie","year":"1993","unstructured":"Powrie F  et al. (1993) Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 5: 1461\u20131471","journal-title":"Int Immunol"},{"key":"BFncponc0666_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0092-8674(04)00335-6","volume":"117","author":"C King","year":"2004","unstructured":"King C  et al. (2004) Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117: 265\u2013277","journal-title":"Cell"},{"key":"BFncponc0666_CR43","first-page":"65","volume":"146","author":"D Neujahr","year":"2005","unstructured":"Neujahr D and Turka LA (2005) Lymphocyte depletion as a barrier to immunological tolerance. Contrib Nephrol 146: 65\u201372","journal-title":"Contrib Nephrol"},{"key":"BFncponc0666_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1172\/JCI0215175","volume":"110","author":"W Dummer","year":"2002","unstructured":"Dummer W  et al. (2002) T cell homeostatic proliferation elicits effective antitumor autoimmunity. J Clin Invest 110: 185\u2013192","journal-title":"J Clin Invest"},{"key":"BFncponc0666_CR45","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.4049\/jimmunol.176.9.5255","volume":"176","author":"PA Antony","year":"2006","unstructured":"Antony PA  et al. (2006) Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. J Immunol 176: 5255\u20135266","journal-title":"J Immunol"},{"key":"BFncponc0666_CR46","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.20041130","volume":"200","author":"MJ Turk","year":"2004","unstructured":"Turk MJ  et al. (2004) Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med 200: 771\u2013782","journal-title":"J Exp Med"},{"key":"BFncponc0666_CR47","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ  et al. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942\u2013949","journal-title":"Nat Med"},{"key":"BFncponc0666_CR48","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/01.cji.0000155049.26787.45","volume":"28","author":"PA Antony","year":"2005","unstructured":"Antony PA and Restifo NP (2005) CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J Immunother 28: 120\u2013128","journal-title":"J Immunother"},{"key":"BFncponc0666_CR49","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.4049\/jimmunol.174.5.2591","volume":"174","author":"PA Antony","year":"2005","unstructured":"Antony PA  et al. (2005) CD8+ T cell immunity against a tumor\/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol 174: 2591\u20132601","journal-title":"J Immunol"},{"key":"BFncponc0666_CR50","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbmt.2005.02.002","volume":"11","author":"M Eyrich","year":"2005","unstructured":"Eyrich M  et al. (2005) Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers. Biol Blood Marrow Transplant 11: 371\u2013382","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFncponc0666_CR51","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1172\/JCI0214989","volume":"109","author":"Y Zhang","year":"2002","unstructured":"Zhang Y  et al. (2002) Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J Clin Invest 109: 1335\u20131344","journal-title":"J Clin Invest"},{"key":"BFncponc0666_CR52","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1158\/1078-0432.CCR-05-1761","volume":"12","author":"A Gelbard","year":"2006","unstructured":"Gelbard A  et al. (2006) Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis. Clin Cancer Res 12: 1897\u20131905","journal-title":"Clin Cancer Res"},{"key":"BFncponc0666_CR53","doi-asserted-by":"publisher","first-page":"7985","DOI":"10.1158\/0008-5472.CAN-04-1525","volume":"64","author":"CT Garnett","year":"2004","unstructured":"Garnett CT  et al. (2004) Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res 64: 7985\u20137994","journal-title":"Cancer Res"},{"key":"BFncponc0666_CR54","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1084\/jem.20052494","volume":"203","author":"EA Reits","year":"2006","unstructured":"Reits EA  et al. (2006) Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 203: 1259\u20131271","journal-title":"J Exp Med"},{"key":"BFncponc0666_CR55","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1002\/eji.200324034","volume":"33","author":"J Ma","year":"2003","unstructured":"Ma J  et al. (2003) Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution. Eur J Immunol 33: 2123\u20132132","journal-title":"Eur J Immunol"},{"key":"BFncponc0666_CR56","first-page":"3914","volume":"62","author":"HM Hu","year":"2002","unstructured":"Hu HM  et al. (2002) Development of antitumor immune responses in reconstituted lymphopenic hosts. Cancer Res 62: 3914\u20133919","journal-title":"Cancer Res"},{"key":"BFncponc0666_CR57","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1073\/pnas.022634999","volume":"99","author":"W Asavaroengchai","year":"2002","unstructured":"Asavaroengchai W  et al. (2002) Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery. Proc Natl Acad Sci USA 99: 931\u2013936","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncponc0666_CR58","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/nm1310","volume":"11","author":"AP Rapoport","year":"2005","unstructured":"Rapoport AP  et al. (2005) Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer. Nat Med 11: 1230\u20131237","journal-title":"Nat Med"},{"key":"BFncponc0666_CR59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.coi.2005.02.002","volume":"17","author":"C Wrzesinski","year":"2005","unstructured":"Wrzesinski C and Restifo NP (2005) Less is more: lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor immunotherapy. Curr Opin Immunol 17: 195\u2013201","journal-title":"Curr Opin Immunol"},{"key":"BFncponc0666_CR60","unstructured":"Wrzesinski C  et al. Hematopoietic stem cells promote the expansion and function of adoptively transferred anti-tumor CD8+ T cells. J Clin Invest, in press"},{"key":"BFncponc0666_CR61","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1182\/blood.V92.11.4464","volume":"92","author":"F Dumont-Girard","year":"1998","unstructured":"Dumont-Girard F  et al. (1998) Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood 92: 4464\u20134471","journal-title":"Blood"},{"key":"BFncponc0666_CR62","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1182\/blood.V96.6.2299","volume":"96","author":"E Roux","year":"2000","unstructured":"Roux E  et al. (2000) Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 96: 2299\u20132303","journal-title":"Blood"},{"key":"BFncponc0666_CR63","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1182\/blood.V90.2.850","volume":"90","author":"A Heitger","year":"1997","unstructured":"Heitger A  et al. (1997) Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation. Blood 90: 850\u2013857","journal-title":"Blood"},{"key":"BFncponc0666_CR64","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1071059","volume":"296","author":"P Matzinger","year":"2002","unstructured":"Matzinger P (2002) The danger model: a renewed sense of self. Science 296: 301\u2013305","journal-title":"Science"},{"key":"BFncponc0666_CR65","first-page":"3031","volume":"48","author":"T Matsumoto","year":"1988","unstructured":"Matsumoto T  et al. (1988) Significance of bacterial flora in abdominal irradiation-induced inhibition of lung metastases. Cancer Res 48: 3031\u20133034","journal-title":"Cancer Res"},{"key":"BFncponc0666_CR66","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.4049\/jimmunol.174.6.3158","volume":"174","author":"WC Kieper","year":"2005","unstructured":"Kieper WC  et al. (2005) Recent immune status determines the source of antigens that drive homeostatic T cell expansion. J Immunol 174: 3158\u20133163","journal-title":"J Immunol"},{"key":"BFncponc0666_CR67","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","volume":"90","author":"GR Hill","year":"1997","unstructured":"Hill GR  et al. (1997) Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90: 3204\u20133213","journal-title":"Blood"},{"key":"BFncponc0666_CR68","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1182\/blood-2004-02-0545","volume":"104","author":"ML Sorror","year":"2004","unstructured":"Sorror ML  et al. (2004) Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities. Blood 104: 961\u2013968","journal-title":"Blood"},{"key":"BFncponc0666_CR69","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1182\/blood-2004-03-0804","volume":"104","author":"R Diaconescu","year":"2004","unstructured":"Diaconescu R  et al. (2004) Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood 104: 1550\u20131558","journal-title":"Blood"},{"key":"BFncponc0666_CR70","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/sj.bmt.1702060","volume":"24","author":"R Abraham","year":"1999","unstructured":"Abraham R  et al. (1999) Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma. Bone Marrow Transplant 24: 1291\u20131297","journal-title":"Bone Marrow Transplant"},{"key":"BFncponc0666_CR71","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/sj.leu.2404010","volume":"20","author":"BL Scott","year":"2005","unstructured":"Scott BL  et al. (2005) Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis. Leukemia 20: 128\u2013135","journal-title":"Leukemia"},{"key":"BFncponc0666_CR72","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.bbmt.2005.07.009","volume":"11","author":"LM Griffith","year":"2005","unstructured":"Griffith LM  et al. (2005) Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005. Biol Blood Marrow Transplant 11: 862\u2013870","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFncponc0666_CR73","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1182\/blood.V99.3.731","volume":"99","author":"P Moreau","year":"2002","unstructured":"Moreau P  et al. (2002) Comparison of 200 mg\/m(2) melphalan and 8 Gy total body irradiation plus 140 mg\/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial. Blood 99: 731\u2013735","journal-title":"Blood"},{"key":"BFncponc0666_CR74","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/sj.bmt.1702771","volume":"27","author":"CI Chen","year":"2001","unstructured":"Chen CI  et al. (2001) Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes. Bone Marrow Transplant 27: 177\u2013182","journal-title":"Bone Marrow Transplant"},{"key":"BFncponc0666_CR75","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1097\/00007890-199704270-00006","volume":"63","author":"SP Kantrow","year":"1997","unstructured":"Kantrow SP  et al. (1997) Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation 63: 1079\u20131086","journal-title":"Transplantation"},{"key":"BFncponc0666_CR76","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0360-3016(01)02589-5","volume":"52","author":"A Della Volpe","year":"2002","unstructured":"Della Volpe A  et al. (2002) Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. Int J Radiat Oncol Biol Phys 52: 483\u2013488","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFncponc0666_CR77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/blood.V93.1.55","volume":"93","author":"B Barlogie","year":"1999","unstructured":"Barlogie B  et al. (1999) Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood 93: 55\u201365","journal-title":"Blood"},{"key":"BFncponc0666_CR78","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/sj.bmt.1704671","volume":"34","author":"RK Burt","year":"2004","unstructured":"Burt RK  et al. (2004) The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis. Bone Marrow Transplant 34: 745\u2013751","journal-title":"Bone Marrow Transplant"},{"key":"BFncponc0666_CR79","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbmt.2004.12.328","volume":"11","author":"BN Savani","year":"2005","unstructured":"Savani BN  et al. (2005) Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant 11: 223\u2013230","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFncponc0666_CR80","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ijrobp.2005.02.032","volume":"63","author":"S Sampath","year":"2005","unstructured":"Sampath S  et al. (2005) Dose response and factors related to interstitial pneumonitis after bone marrow transplant. Int J Radiat Oncol Biol Phys 63: 876\u2013884","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFncponc0666_CR81","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1182\/blood-2003-03-0877","volume":"102","author":"RK Burt","year":"2003","unstructured":"Burt RK  et al. (2003) Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood 102: 2373\u20132378","journal-title":"Blood"},{"key":"BFncponc0666_CR82","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1053\/bbmt.2002.v8.abbmt080608","volume":"8","author":"W Blum","year":"2002","unstructured":"Blum W  et al. (2002) Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity. Biol Blood Marrow Transplant 8: 608\u2013618","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFncponc0666_CR83","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1182\/blood.V83.11.3384.3384","volume":"83","author":"R Storb","year":"1994","unstructured":"Storb R  et al. (1994) Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts. Blood 83: 3384\u20133389","journal-title":"Blood"},{"key":"BFncponc0666_CR84","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1182\/blood.V74.3.1139.1139","volume":"74","author":"R Storb","year":"1989","unstructured":"Storb R  et al. (1989) Comparison of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts. Blood 74: 1139\u20131143","journal-title":"Blood"},{"key":"BFncponc0666_CR85","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1182\/blood-2003-07-2346","volume":"105","author":"M Girgis","year":"2005","unstructured":"Girgis M  et al. (2005) Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide. Blood 105: 3035\u20133041","journal-title":"Blood"},{"key":"BFncponc0666_CR86","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.bbmt.2003.12.002","volume":"10","author":"C Hallemeier","year":"2004","unstructured":"Hallemeier C  et al. (2004) Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants. Biol Blood Marrow Transplant 10: 310\u2013319","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFncponc0666_CR87","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1259\/0007-1285-39-463-547","volume":"39","author":"S Vatistas","year":"1966","unstructured":"Vatistas S and Hornsey S (1966) Radiation-induced protein loss into the gastrointestinal tract. Br J Radiol 39: 547\u2013550","journal-title":"Br J Radiol"},{"key":"BFncponc0666_CR88","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/00002371-200205000-00007","volume":"25","author":"ME Dudley","year":"2002","unstructured":"Dudley ME  et al. (2002) A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma. J Immunother 25: 243\u2013251","journal-title":"J Immunother"},{"key":"BFncponc0666_CR89","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML  et al. (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106: 2912\u20132919","journal-title":"Blood"},{"key":"BFncponc0666_CR90","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1378\/chest.101.5.1257","volume":"101","author":"SW Crawford","year":"1992","unstructured":"Crawford SW and Fisher L (1992) Predictive value of pulmonary function tests before marrow transplantation. Chest 101: 1257\u20131264","journal-title":"Chest"},{"key":"BFncponc0666_CR91","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1172\/JCI24480","volume":"115","author":"L Gattinoni","year":"2005","unstructured":"Gattinoni L  et al. (2005) Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J Clin Invest 115: 1616\u20131626","journal-title":"J Clin Invest"},{"key":"BFncponc0666_CR92","doi-asserted-by":"publisher","first-page":"7046","DOI":"10.4049\/jimmunol.175.10.7046","volume":"175","author":"J Zhou","year":"2005","unstructured":"Zhou J  et al. (2005) Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J Immunol 175: 7046\u20137052","journal-title":"J Immunol"},{"key":"BFncponc0666_CR93","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1158\/1078-0432.CCR-05-1485","volume":"12","author":"L Duval","year":"2006","unstructured":"Duval L  et al. (2006) Adoptive transfer of allogeneic cytotoxic T lymphocytes equipped with a HLA-A2 restricted MART-1 T-cell receptor: a phase I trial in metastatic melanoma. Clin Cancer Res 12: 1229\u20131236","journal-title":"Clin Cancer Res"},{"key":"BFncponc0666_CR94","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1182\/blood.V80.2.551.551","volume":"80","author":"PT Adams","year":"1992","unstructured":"Adams PT  et al. (1992) Detection of circulating donor white blood cells in patients receiving multiple transfusions. Blood 80: 551\u2013555","journal-title":"Blood"},{"key":"BFncponc0666_CR95","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.V85.5.1207.bloodjournal8551207","volume":"85","author":"TH Lee","year":"1995","unstructured":"Lee TH  et al. (1995) Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood 85: 1207\u20131214","journal-title":"Blood"},{"key":"BFncponc0666_CR96","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","volume":"105","author":"JS Miller","year":"2005","unstructured":"Miller JS  et al. (2005) Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105: 3051\u20133057","journal-title":"Blood"},{"key":"BFncponc0666_CR97","first-page":"7","volume":"2","author":"V Dutoit","year":"2002","unstructured":"Dutoit V  et al. (2002) Functional analysis of HLA-A*0201\/Melan-A peptide multimer+ CD8+ T cells isolated from an HLA-A*0201- donor: exploring tumor antigen allorestricted recognition. Cancer Immun 2: 7","journal-title":"Cancer Immun"},{"key":"BFncponc0666_CR98","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.4049\/jimmunol.176.4.2330","volume":"176","author":"MJ Pittet","year":"2006","unstructured":"Pittet MJ  et al. (2006) Ex vivo characterization of allo-MHC-restricted T cells specific for a single MHC-peptide complex. J Immunol 176: 2330\u20132336","journal-title":"J Immunol"},{"key":"BFncponc0666_CR99","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1182\/blood-2003-11-3903","volume":"103","author":"P Savage","year":"2004","unstructured":"Savage P  et al. (2004) Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen. Blood 103: 4613\u20134615","journal-title":"Blood"},{"key":"BFncponc0666_CR100","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.4049\/jimmunol.160.12.6204","volume":"160","author":"T Haque","year":"1998","unstructured":"Haque T  et al. (1998) Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol 160: 6204\u20136209","journal-title":"J Immunol"},{"key":"BFncponc0666_CR101","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(02)09672-1","volume":"360","author":"T Haque","year":"2002","unstructured":"Haque T  et al. (2002) Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet 360: 436\u2013442","journal-title":"Lancet"},{"key":"BFncponc0666_CR102","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/annonc\/mdh027","volume":"15","author":"P Comoli","year":"2004","unstructured":"Comoli P  et al. (2004) Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma. Ann Oncol 15: 113\u2013117","journal-title":"Ann Oncol"},{"key":"BFncponc0666_CR103","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","volume":"333","author":"EA Walter","year":"1995","unstructured":"Walter EA  et al. (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333: 1038\u20131044","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"BFncponc0666_CR104","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1093\/annonc\/9.suppl_5.S129","volume":"9","author":"CM Rooney","year":"1998","unstructured":"Rooney CM  et al. (1998) Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells. Ann Oncol 9 (Suppl 5): S129\u2013S132","journal-title":"Ann Oncol"},{"key":"BFncponc0666_CR105","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1399-0039.2004.00188.x","volume":"63","author":"A Whitelegg","year":"2004","unstructured":"Whitelegg A and Barber LD (2004) The structural basis of T-cell allorecognition. Tissue Antigens 63: 101\u2013108","journal-title":"Tissue Antigens"},{"key":"BFncponc0666_CR106","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.4049\/jimmunol.175.3.1706","volume":"175","author":"AM Whitelegg","year":"2005","unstructured":"Whitelegg AM  et al. (2005) Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers. J Immunol 175: 1706\u20131714","journal-title":"J Immunol"},{"key":"BFncponc0666_CR107","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/ni1001-962","volume":"2","author":"T Stanislawski","year":"2001","unstructured":"Stanislawski T  et al. (2001) Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat Immunol 2: 962\u2013970","journal-title":"Nat Immunol"},{"key":"BFncponc0666_CR108","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/nri1729","volume":"5","author":"MH Kershaw","year":"2005","unstructured":"Kershaw MH  et al. (2005) Supernatural T cells: genetic modification of T cells for cancer therapy. Nat Rev Immunol 5: 928\u2013940","journal-title":"Nat Rev Immunol"},{"key":"BFncponc0666_CR109","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1126\/science.1129003","volume":"314","author":"RA Morgan","year":"2006","unstructured":"Morgan RA  et al. (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314: 126\u2013129","journal-title":"Science"},{"key":"BFncponc0666_CR110","first-page":"229","volume":"109","author":"RH Voss","year":"2005","unstructured":"Voss RH  et al. (2005) Designing TCR for cancer immunotherapy. Methods Mol Med 109: 229\u2013256","journal-title":"Methods Mol Med"},{"key":"BFncponc0666_CR111","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.immuni.2004.12.005","volume":"22","author":"J Kuball","year":"2005","unstructured":"Kuball J  et al. (2005) Cooperation of human tumor-reactive CD4+ and CD8+ T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR. Immunity 22: 117\u2013129","journal-title":"Immunity"},{"key":"BFncponc0666_CR112","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.4049\/jimmunol.175.9.5799","volume":"175","author":"CJ Cohen","year":"2005","unstructured":"Cohen CJ  et al. (2005) Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR. J Immunol 175: 5799\u20135808","journal-title":"J Immunol"},{"key":"BFncponc0666_CR113","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ni1055","volume":"5","author":"TM Schmitt","year":"2004","unstructured":"Schmitt TM  et al. (2004) Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nat Immunol 5: 410\u2013417","journal-title":"Nat Immunol"},{"key":"BFncponc0666_CR114","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1172\/JCI24731","volume":"115","author":"RA Clark","year":"2005","unstructured":"Clark RA  et al. (2005) Human skin cells support thymus-independent T cell development. J Clin Invest 115: 3239\u20133249","journal-title":"J Clin Invest"},{"key":"BFncponc0666_CR115","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1126\/science.1122927","volume":"311","author":"O Boyman","year":"2006","unstructured":"Boyman O  et al. (2006) Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924\u20131927","journal-title":"Science"},{"key":"BFncponc0666_CR116","doi-asserted-by":"crossref","unstructured":"Gattinoni L et al. (2006) CTLA-4 dysregulation of self\/tumor-reactive CD8+ T cell function is CD4+ T cell-dependent. Blood [doi: 10.1182\/blood-2006-07-034066]","DOI":"10.1182\/blood-2006-07-034066"}],"container-title":["Nature Clinical Practice Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncponc0666","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncponc0666.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncponc0666.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T07:25:10Z","timestamp":1744356310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncponc0666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,1]]},"references-count":116,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12,1]]}},"alternative-id":["BFncponc0666"],"URL":"https:\/\/doi.org\/10.1038\/ncponc0666","relation":{},"ISSN":["1743-4254","1743-4262"],"issn-type":[{"value":"1743-4254","type":"print"},{"value":"1743-4262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,1]]},"assertion":[{"value":"12 April 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}